Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Long-COVID symptoms can last more than a year and change over time.

COVID-19 infection may cause hair loss.

Covid-19 can cause hair loss due to immune and psychological factors.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

The treatment might help COVID-19 related hair loss, but more research is needed.

No single biomarker is reliable enough for diagnosing and assessing SLE.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

About 61% of women who had COVID-19 experienced hair loss afterward.

Passiflora incarnata may help with anxiety and sleep issues but has side effects; teleconsultation for heart failure can improve quality of life; increased screen time for children during the pandemic led to more clinical complaints; older and severely affected COVID-19 patients are more likely to have long-term symptoms.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

COVID-19 infection may cause hair loss a few months after recovery.

New understanding and treatments for hair loss are improving, but more research is needed.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.